Cargando…

Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review

OBJECTIVES: Herpes simplex virus 1 (HSV-1) is the main pathogen responsible for herpes infections. In 13–30% of the cases, primary HSV-1 leads to the primary herpetic gingivostomatitis (PHGS), often a self-limiting infection; however, it can limit the ability to drink/eat with, sometimes, the need f...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppola, Noemi, Cantile, Tiziana, Adamo, Daniela, Canfora, Federica, Baldares, Stefania, Riccitiello, Francesco, Musella, Gennaro, Mignogna, Michele Davide D., Leuci, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630243/
https://www.ncbi.nlm.nih.gov/pubmed/37733027
http://dx.doi.org/10.1007/s00784-023-05250-5
_version_ 1785146008147066880
author Coppola, Noemi
Cantile, Tiziana
Adamo, Daniela
Canfora, Federica
Baldares, Stefania
Riccitiello, Francesco
Musella, Gennaro
Mignogna, Michele Davide D.
Leuci, Stefania
author_facet Coppola, Noemi
Cantile, Tiziana
Adamo, Daniela
Canfora, Federica
Baldares, Stefania
Riccitiello, Francesco
Musella, Gennaro
Mignogna, Michele Davide D.
Leuci, Stefania
author_sort Coppola, Noemi
collection PubMed
description OBJECTIVES: Herpes simplex virus 1 (HSV-1) is the main pathogen responsible for herpes infections. In 13–30% of the cases, primary HSV-1 leads to the primary herpetic gingivostomatitis (PHGS), often a self-limiting infection; however, it can limit the ability to drink/eat with, sometimes, the need for hospitalization. Multiple therapeutic methods have been proposed. This systematic review aims to collect and critically appraise the available evidence about the clinical management of PHGS. MATERIALS AND METHODS: Literature search including three databases (PubMed, Scopus, Embase), study design, and data analysis were performed following PRISMA guidelines, according to the PICO tool (PROSPERO n° CRD42023391386). Risk of bias was assessed with RoB 2 and ROBINS-I. RESULTS: Five studies on a total of 364 patients (average age: 7.6 years) were identified. The treatment regimens were summarized in acyclovir; acyclovir + honey; fluids and analgesic; maalox + diphenhydramine; lidocaine; chlorhexidine (CHX); CHX + ialuronic acid; CHX + Mucosyte®; antimicrobial photodynamic therapy (aPDT); topical antiviral; topical antiviral + aPDT; and others. CONCLUSIONS: Although PHGS is a disease with a high worldwide prevalence, the lack of consensus about therapeutic management indicates gaps in existing evidence. Most of the proposed treatment consists in symptomatic drugs with empiric regimens which are ineffective for the viral replication. The main limit to realize randomized clinical trial is due to the rapid onset and remission of the disease. In fact, the diagnostic delay, estimated in 72 h, decreases the effectiveness of any antiviral drugs. CLINICAL RELEVANCE: Out of the five studies included in this systematic review, only one was able to provide some weak evidence that ACV is an effective treatment, improving healing of oral lesions and reducing duration of symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00784-023-05250-5.
format Online
Article
Text
id pubmed-10630243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106302432023-11-14 Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review Coppola, Noemi Cantile, Tiziana Adamo, Daniela Canfora, Federica Baldares, Stefania Riccitiello, Francesco Musella, Gennaro Mignogna, Michele Davide D. Leuci, Stefania Clin Oral Investig Review OBJECTIVES: Herpes simplex virus 1 (HSV-1) is the main pathogen responsible for herpes infections. In 13–30% of the cases, primary HSV-1 leads to the primary herpetic gingivostomatitis (PHGS), often a self-limiting infection; however, it can limit the ability to drink/eat with, sometimes, the need for hospitalization. Multiple therapeutic methods have been proposed. This systematic review aims to collect and critically appraise the available evidence about the clinical management of PHGS. MATERIALS AND METHODS: Literature search including three databases (PubMed, Scopus, Embase), study design, and data analysis were performed following PRISMA guidelines, according to the PICO tool (PROSPERO n° CRD42023391386). Risk of bias was assessed with RoB 2 and ROBINS-I. RESULTS: Five studies on a total of 364 patients (average age: 7.6 years) were identified. The treatment regimens were summarized in acyclovir; acyclovir + honey; fluids and analgesic; maalox + diphenhydramine; lidocaine; chlorhexidine (CHX); CHX + ialuronic acid; CHX + Mucosyte®; antimicrobial photodynamic therapy (aPDT); topical antiviral; topical antiviral + aPDT; and others. CONCLUSIONS: Although PHGS is a disease with a high worldwide prevalence, the lack of consensus about therapeutic management indicates gaps in existing evidence. Most of the proposed treatment consists in symptomatic drugs with empiric regimens which are ineffective for the viral replication. The main limit to realize randomized clinical trial is due to the rapid onset and remission of the disease. In fact, the diagnostic delay, estimated in 72 h, decreases the effectiveness of any antiviral drugs. CLINICAL RELEVANCE: Out of the five studies included in this systematic review, only one was able to provide some weak evidence that ACV is an effective treatment, improving healing of oral lesions and reducing duration of symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00784-023-05250-5. Springer Berlin Heidelberg 2023-09-21 2023 /pmc/articles/PMC10630243/ /pubmed/37733027 http://dx.doi.org/10.1007/s00784-023-05250-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Coppola, Noemi
Cantile, Tiziana
Adamo, Daniela
Canfora, Federica
Baldares, Stefania
Riccitiello, Francesco
Musella, Gennaro
Mignogna, Michele Davide D.
Leuci, Stefania
Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
title Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
title_full Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
title_fullStr Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
title_full_unstemmed Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
title_short Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
title_sort supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630243/
https://www.ncbi.nlm.nih.gov/pubmed/37733027
http://dx.doi.org/10.1007/s00784-023-05250-5
work_keys_str_mv AT coppolanoemi supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT cantiletiziana supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT adamodaniela supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT canforafederica supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT baldaresstefania supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT riccitiellofrancesco supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT musellagennaro supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT mignognamicheledavided supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview
AT leucistefania supportivecareandantiviraltreatmentsinprimaryherpeticgingivostomatitisasystematicreview